Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
DBLG1 System, the AID (Automated Insulin Delivery) system from Diabeloop individualizes treatment by automating insulin decisions. It connects a CGM...
Diabeloop announced today the appointment of Catherine Dunand as Chairman of the Board of Directors, succeeding Dr Guillaume Charpentier. Dr....
Diabeloop announced today that it has obtained CE marking for its innovative and adjustable technological solution: DBL-hu. DBL-hu improves glycemic...
The French company Diabeloop, a pioneer in therapeutic AI, and Terumo Corporation, a global leader in medical technology, announced today that they...
The Automated Insulin Delivery (AID) solutions developed by Diabeloop embed therapeutic artificial intelligence to automate and personalize Type 1...
Pioneering technological breakthroughs in diabetes treatment The solutions developed by Diabeloop leverage artificial intelligence to automate and...
Dance without a worry, travel feeling free, seize every opportunity. Diabeloop believes that every person with type 1 diabetes should be able to live ...
Diabeloop, the company behind the next generation automated insulin delivery system for Type 1 diabetes, has appointed Meinhard F. Schmidt as its new ...
The French company Diabeloop announces the publication in the international journal "The Lancet Digital Health" of the finalized results of the major ...
Making its second appearance at CES, the world's leading technology event, on 8-11 January 2019 at Las Vegas, the Grenoble-based firm Diabeloop,...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.